# Medicare Still Ignores Cannabinoids, Seniors Still Notice #8 > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/senior-cannabis-care-medicare-access-barriers/ > **Published:** 2026-03-20T17:40:34-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T15:54:32-04:00 > **Clinical Summary:** Explore senior cannabis care challenges due to Medicare access barriers and the impact on cannabinoid therapy for older adults. --- CED Clinical Relevance  #78Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. 💡 Cannabis Education  |  CED Clinic Senior CareMedicareAccess Barriers[Healthcare Policy](https://cedclinic.com/cannabis-legalization-in-canada-new-opportunities/)Patient Advocacy Format One-panel meme Audience Older adults and caregivers Primary Topic Senior cannabis care Why This Matters Medicare’s exclusion of [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) creates significant access barriers for seniors, who often have complex medical conditions that could benefit from [cannabinoid therapy](https://cedclinic.com/unknown-cannabinoid-receptor-brain-damage-relief/). This policy disconnect forces older adults to navigate cannabis care without insurance coverage, creating both financial and clinical safety challenges. Clinical Summary Despite growing evidence for cannabis in managing conditions common among seniors—including [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/), sleep disorders, and appetite issues—Medicare continues to classify cannabis as a Schedule I substance, making it ineligible for coverage. This leaves seniors paying out-of-pocket for both cannabis products and specialized medical consultations, often while managing fixed incomes. The irony is particularly stark given that seniors represent one of the fastest-growing demographics of cannabis patients, with many reporting meaningful clinical benefits. Dr. Caplan’s Take “I see 75-year-olds choosing between their blood pressure medication and [cannabis for arthritis](https://cedclinic.com/cannabinoid-treatments-rheumatic-diseases-efficacy-safety/) pain—a choice they shouldn’t have to make. Medicare’s stance ignores both clinical reality and patient need.” Clinical Perspective 🧠 Seniors considering cannabis should work with knowledgeable physicians who can provide proper guidance even without insurance coverage. Understanding dosing, drug interactions, and product quality becomes even more critical when patients are self-paying and may be tempted to seek cheaper, unregulated alternatives. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Medicare%20still%20ignores%20cannabinoids%20seniors%20still%20notice%20%238%20%40drcaplan&url=https%3A//example.com/meme/medicare-still-ignores-cannabinoids-seniors-still-notice-8)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//example.com/meme/medicare-still-ignores-cannabinoids-seniors-still-notice-8)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Medicare%20still%20ignores%20cannabinoids%20seniors%20still%20notice%20%238%20--%20via%20%40drcaplan.bsky.social%20https%3A//example.com/meme/medicare-still-ignores-cannabinoids-seniors-still-notice-8)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://example.com/meme/medicare-still-ignores-cannabinoids-seniors-still-notice-8](https://example.com/meme/medicare-still-ignores-cannabinoids-seniors-still-notice-8) ## FAQ ### What cannabis care costs do seniors on Medicare pay themselves? Seniors pay out of pocket for both cannabis products and specialized medical consultations, because Medicare coverage does not extend to cannabis. The article points out that many older adults carry these costs while managing fixed incomes. ### Are older adults a growing group of medical cannabis patients? Yes. The article describes seniors as one of the fastest-growing demographics of cannabis patients, with many reporting meaningful clinical benefits. It calls this growth ironic given that Medicare still excludes cannabis from coverage, leaving these patients to pay for their care on their own. {“@context”:”https://schema.org”,”@type”:”Article”} RELATED READING AT CED CLINIC Continue exploring the evidence [High-tech help: Cannabis kiosks aim to simplify access for seniors – YouTube](https://cedclinic.com/cannabis-kiosks-for-seniors-access-safety/) Learn how innovative cannabis kiosks are designed to improve access and ease of use for senior patients navigating cannabis care. [Watch Now](https://cedclinic.com/cannabis-kiosks-for-seniors-access-safety/) [Why Older Adults Increasingly Seek Cannabis for Pain, Mental Health, & Sleep](https://cedclinic.com/why-older-adults-increasingly-seek-cannabis-for-pain-mental-health-sleep/) Explore the growing trend of cannabis use among older adults for managing pain, mental health, and sleep disorders. [Read More](https://cedclinic.com/why-older-adults-increasingly-seek-cannabis-for-pain-mental-health-sleep/) [Cannabis Insurance and the Fight for Patient Access | Sponsored | rutlandherald.com](https://cedclinic.com/cannabis-insurance-and-the-fight-for-patient-access-sponsored-rutlandherald-com/) Understand the ongoing challenges and advocacy efforts surrounding cannabis insurance coverage and patient access. [Learn More](https://cedclinic.com/cannabis-insurance-and-the-fight-for-patient-access-sponsored-rutlandherald-com/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).